At Panagora’s 7th Annual Digital Biomarkers in Clinical Trials Summit, Novartis presented a groundbreaking study on digital home-based assessments for patients with amyotrophic lateral sclerosis (ALS). Vanessa Vallejo, Senior Clinical Scientist, and Arne Müller, Associate Director and Senior Principal Data Scientist for Clinical Digital Endpoints, shared their comprehensive findings, highlighting the potential of digital endpoints to revolutionize ALS clinical trials.